Skip to main content
Top
Published in: Archives of Virology 8/2012

01-08-2012 | Original Article

HBV/D1: a major HBV subgenotype circulating in Uyghur patients with chronic HBV infection in Xinjiang, China

Authors: Jingjing Nie, Jie Li, Kuixia Sun, Mishu Sun, Jie Chen, Junfeng Ma, Ling Yan, Hui Zhuang

Published in: Archives of Virology | Issue 8/2012

Login to get access

Abstract

Each hepatitis B virus (HBV) genotype and subgenotype is associated with a particular geographic distribution, ethnicity, and anthropological history. The present study investigated the genomic characteristics of HBV from Uyghur patients with chronic HBV infection in Xinjiang, China. Among the 53 Uyghur patients enrolled, HBV/D was found to be the dominant strain, with 64.2 % (34/53), 60.4 % (32/53) with HBV/D1 and 3.8 % (2/53) with HBV/D3. In addition to these findings, 3.8 % HBV/B (2/53), 5.7 % HBV/C (3/53), 11.3 % C+D (6/53), 7.5 % B+D (4/53), 3.8 % B+C (2/53) and 3.8 % B+C+D (2/53) were also detected. The full-length genome of seven HBV/D1 isolates and 144 reference sequences retrieved from GenBank were compared and analyzed by biological information methods. These results demonstrate that the D1 isolates from Xinjiang and Central Asia show a close genetic proximity (0.013±0.0007). Furthermore, four unique amino acid substitutions (sp82Asn, sp89His, rt129Leu, rt151Leu) representing background polymorphisms rather than drug resistance mutations or immune escape variants were found in the Uyghur patients of Xinjiang, but these were seldom found in HBV/D1 strains from other regions (0 %-14.3 %). This study indicates that in Xinjiang, unlike HBV-infected Han patients, HBV/D1 is the predominant strain among HBV-infected Uyghur people. Although genetic distance analysis suggests that the HBV/D1 isolates from Xinjiang are closely related to those from Central Asia, unique amino acid substitutions suggest independent evolution of HBV in the Uyghur patients of Xinjiang.
Appendix
Available only for authorised users
Literature
1.
go back to reference Michitaka K, Tanaka Y, Horiike N, Duong TN, Chen Y, Matsuura K, Hiasa Y, Mizokami M, Onji M (2006) Tracing the history of hepatitis B virus genotype D in western Japan. J Med Virol 78:44–52PubMedCrossRef Michitaka K, Tanaka Y, Horiike N, Duong TN, Chen Y, Matsuura K, Hiasa Y, Mizokami M, Onji M (2006) Tracing the history of hepatitis B virus genotype D in western Japan. J Med Virol 78:44–52PubMedCrossRef
3.
go back to reference Shi Z, Li X, Ma L, Yang Y (2010) Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis 14:e622–e634PubMedCrossRef Shi Z, Li X, Ma L, Yang Y (2010) Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis 14:e622–e634PubMedCrossRef
4.
go back to reference Shi Z, Yang Y, Ma L, Li X, Schreiber A (2010) Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 116:147–159PubMedCrossRef Shi Z, Yang Y, Ma L, Li X, Schreiber A (2010) Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 116:147–159PubMedCrossRef
5.
go back to reference Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83:2059–2073PubMed Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83:2059–2073PubMed
6.
go back to reference Huy TTT, Ngoc TT, Abe K (2008) New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 82:5657–5663CrossRef Huy TTT, Ngoc TT, Abe K (2008) New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 82:5657–5663CrossRef
7.
go back to reference Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO (1992) Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 73:1201–1208PubMedCrossRef Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO (1992) Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 73:1201–1208PubMedCrossRef
8.
go back to reference Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69:2575–2583PubMedCrossRef Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69:2575–2583PubMedCrossRef
9.
go back to reference Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81:67–74PubMed Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81:67–74PubMed
10.
go back to reference Liang XF, Bi SL, Yang WZ, Wang LD, Cui G, Cui FQ, Zhang Y, Liu JH, Gong XH, Chen YS, Wang FZ, Zheng H, Wang F, Guo J, Jia ZY, Ma JC, Wang HQ, Luo HM, Li L, Jin SG, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550–6557PubMedCrossRef Liang XF, Bi SL, Yang WZ, Wang LD, Cui G, Cui FQ, Zhang Y, Liu JH, Gong XH, Chen YS, Wang FZ, Zheng H, Wang F, Guo J, Jia ZY, Ma JC, Wang HQ, Luo HM, Li L, Jin SG, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550–6557PubMedCrossRef
11.
go back to reference Li YJ, Zhuang H, Li J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ (2005) Distribution and clinical significance of hepatitis B virus (HBV) genotypes and subtypes in HBV-infected patients. Chin J Hepatol 13:724–729 Li YJ, Zhuang H, Li J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ (2005) Distribution and clinical significance of hepatitis B virus (HBV) genotypes and subtypes in HBV-infected patients. Chin J Hepatol 13:724–729
12.
go back to reference Gao JW, Li YJ, Zhuang H, Li J, Wang J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ (2007) Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B virus infection among 12 cities in China. Chin J Epidemiol 28:315–318 Gao JW, Li YJ, Zhuang H, Li J, Wang J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ (2007) Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B virus infection among 12 cities in China. Chin J Epidemiol 28:315–318
13.
go back to reference Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J (2005) Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 12:609–617PubMedCrossRef Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J (2005) Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 12:609–617PubMedCrossRef
14.
go back to reference Zhou B, Xiao L, Wang Z, Chang ET, Chen J, Hou J (2011) Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau. PLoS One 6:e18708PubMedCrossRef Zhou B, Xiao L, Wang Z, Chang ET, Chen J, Hou J (2011) Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau. PLoS One 6:e18708PubMedCrossRef
16.
go back to reference Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association (2007) Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J 120:2159–2173 Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association (2007) Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J 120:2159–2173
17.
go back to reference Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H (1995) A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69:5437–5444PubMed Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H (1995) A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69:5437–5444PubMed
18.
go back to reference Tallo T, Tefanova V, Priimagi L, Schmidt J, Katargina O, Michailov M, Mukomolov S, Magnius L, Norder H (2008) D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol 89:1829–1839PubMedCrossRef Tallo T, Tefanova V, Priimagi L, Schmidt J, Katargina O, Michailov M, Mukomolov S, Magnius L, Norder H (2008) D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol 89:1829–1839PubMedCrossRef
19.
go back to reference Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425PubMed Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425PubMed
20.
go back to reference Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120PubMedCrossRef Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120PubMedCrossRef
21.
go back to reference Xu H, Zhang YX, Wei L, Xiao L, Lu XB (2005) Relationship between the genotypes of hepatitis B virus and clinical courses in groups of the Han nationality in XinJiang. J Clin Hepatol 8:11–15 Xu H, Zhang YX, Wei L, Xiao L, Lu XB (2005) Relationship between the genotypes of hepatitis B virus and clinical courses in groups of the Han nationality in XinJiang. J Clin Hepatol 8:11–15
22.
go back to reference Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef
23.
go back to reference Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, Mizokami M, Chakravarty R (2006) Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol 78:1164–1174PubMedCrossRef Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, Mizokami M, Chakravarty R (2006) Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol 78:1164–1174PubMedCrossRef
24.
go back to reference Lusida MI, Nugrahaputra VE, Soetjipto Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H (2008) Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46:2160–2166PubMedCrossRef Lusida MI, Nugrahaputra VE, Soetjipto Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H (2008) Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46:2160–2166PubMedCrossRef
25.
go back to reference Meldal BHM, Moula NM, Barnes IHA, Boukef K, Allain JP (2009) A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 90:1622–1628PubMedCrossRef Meldal BHM, Moula NM, Barnes IHA, Boukef K, Allain JP (2009) A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 90:1622–1628PubMedCrossRef
26.
go back to reference Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok ASF (2003) Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 125:444–451PubMedCrossRef Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok ASF (2003) Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 125:444–451PubMedCrossRef
27.
go back to reference Baig S, Siddiqui A, Chakravarty R, Moatter T (2009) Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Res Notes 2:1PubMedCrossRef Baig S, Siddiqui A, Chakravarty R, Moatter T (2009) Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Res Notes 2:1PubMedCrossRef
28.
go back to reference Cooksley WGE (2010) Do we need to determine viral genotype in treating chronic hepatitis B? J Viral Hepatitis 17:601–610 Cooksley WGE (2010) Do we need to determine viral genotype in treating chronic hepatitis B? J Viral Hepatitis 17:601–610
29.
go back to reference Comas D, Calafell F, Mateu E, Perez-Lezaun A, Bosch E, Martinez-Arias R, Clarimon J, Facchini F, Fiori G, Luiselli D, Pettener D, Bertranpetit J (1998) Trading genes along the silk road: mtDNA sequences and the origin of central Asian populations. Am J Hum Genet 63:1824–1838PubMedCrossRef Comas D, Calafell F, Mateu E, Perez-Lezaun A, Bosch E, Martinez-Arias R, Clarimon J, Facchini F, Fiori G, Luiselli D, Pettener D, Bertranpetit J (1998) Trading genes along the silk road: mtDNA sequences and the origin of central Asian populations. Am J Hum Genet 63:1824–1838PubMedCrossRef
30.
go back to reference Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153–1168PubMedCrossRef Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153–1168PubMedCrossRef
31.
go back to reference Ghany M, Liang TJ (2007) Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132:1574–1585PubMedCrossRef Ghany M, Liang TJ (2007) Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132:1574–1585PubMedCrossRef
32.
go back to reference Bartholomeusz A, Schaefer S (2004) Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol 14:3–16PubMedCrossRef Bartholomeusz A, Schaefer S (2004) Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol 14:3–16PubMedCrossRef
33.
go back to reference Naito H, Hayashi S, Abe K (2001) Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 39:362–364PubMedCrossRef Naito H, Hayashi S, Abe K (2001) Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 39:362–364PubMedCrossRef
Metadata
Title
HBV/D1: a major HBV subgenotype circulating in Uyghur patients with chronic HBV infection in Xinjiang, China
Authors
Jingjing Nie
Jie Li
Kuixia Sun
Mishu Sun
Jie Chen
Junfeng Ma
Ling Yan
Hui Zhuang
Publication date
01-08-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 8/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1325-8

Other articles of this Issue 8/2012

Archives of Virology 8/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine